Digital platform for early psychosis care
Part of Mental health clinical trials.
This study tests if a digital platform can help people with early psychosis stay engaged in treatment and improve their recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 40 years old
- Have had a first psychotic episode, be in the critical period after psychosis, or be at ultra-high risk for psychosis
- Currently receiving treatment in an early intervention program for psychosis
- Have a mobile phone, laptop, or tablet to use the platform
- Be comfortable using a digital device and the platform
- Speak Catalan or Spanish
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a self-guided cognitive training program designed for young people who recently had their first episode of psychosis. It aims to improve thinking skills and daily function through exercises you can do at home.
This study tests whether a smartphone app can help prevent relapse in people with behavioral disorders. If you speak Spanish, have a smartphone, and are willing to use the app, you may be able to join.
This study tests if a smartphone app can help manage mood symptoms in people with early psychosis. It uses the phone's sensors to adjust the support you receive.
This study tests a digital program designed to encourage young people to seek help for early signs of psychosis. It aims to see if online messages can increase connections to care.
This trial tests a smartphone-based program to help people manage anxiety and depression after a health risk assessment. It may be a good fit if you live in Spain or Chile, are 18–65, and have not been in recent psychological treatment.
This trial tests a digital tool designed to help young people recognize early signs of mental health conditions and take steps toward getting help. It may be a good fit if you are between 12 and 29, live near certain research sites, and can complete a short screening questionnaire in English.
Hear when a new Device Adherence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.